Home > Compound List > Compound details
2022-85-7 molecular structure
click picture or here to close

6-amino-5-fluoro-1,2-dihydropyrimidin-2-one

ChemBase ID: 970
Molecular Formular: C4H4FN3O
Molecular Mass: 129.0924632
Monoisotopic Mass: 129.03383998
SMILES and InChIs

SMILES:
Fc1c([nH]c(=O)nc1)N
Canonical SMILES:
Nc1c(F)cnc(=O)[nH]1
InChI:
InChI=1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9)
InChIKey:
XRECTZIEBJDKEO-UHFFFAOYSA-N

Cite this record

CBID:970 http://www.chembase.cn/molecule-970.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
6-amino-5-fluoro-1,2-dihydropyrimidin-2-one
IUPAC Traditional name
flucytosine
Brand Name
Ancobon
Ancotil
Synonyms
5-FC
5-Fluorocystosine
5-Fluorocytosin
5-Fluorocytosine
5-Flurocytosine
Flucytosin
Fluocytosine
Fluorcytosine
Flucytosine
5-Fluoro cytosine
6-amino-5-fluoro-1,2-dihydropyrimidin-2-one
5-Fluorocytosine
CAS Number
2022-85-7
MDL Number
MFCD00006035
PubChem SID
46504735
160964433
PubChem CID
3366

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 8.163184  H Acceptors
H Donor LogD (pH = 5.5) -0.9489975 
LogD (pH = 7.4) -1.0088187  Log P -0.94816285 
Molar Refractivity 38.2177 cm3 Polarizability 10.144018 Å3
Polar Surface Area 67.48 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P -0.24  LOG S -1.83 
Solubility (Water) 1.92e+00 g/l 

PROPERTIES

PROPERTIES

Physical Property Product Information Bioassay(PubChem)
Solubility
10.5 g/L expand Show data source
Apperance
white crystalline powder expand Show data source
Melting Point
295 - 297°C expand Show data source
Hydrophobicity(logP)
-1.1 expand Show data source
-1.772 expand Show data source
Purity
95% expand Show data source
98% expand Show data source
99% expand Show data source

DETAILS

DETAILS

DrugBank DrugBank
DrugBank - DB01099 external link
Item Information
Drug Groups approved
Description A fluorinated cytosine analog that is used as an antifungal agent. [PubChem]
Indication For the treatment (in combination with amphotericin B) of serious infections caused by susceptible strains of Candida (septicemia, endocarditis and urinary system infections) and/or Cryptococcus (meningitis and pulmonary infections).
Pharmacology Flucytosine is an antimetabolite that acts as an antifungal agent with in vitro and in vivo activity against Candida and Cryptococcus. Flucytosine enters the fungal cell via cytosine permease; thus, flucytosine is metabolized to 5-fluorouracil within fungal organisms. The 5-fluorouracil is extensively incorporated into fungal RNA and inhibits synthesis of both DNA and RNA. The result is unbalanced growth and death of the fungal organism. Antifungal synergism between Ancobon and polyene antibiotics, particularly amphotericin B, has been reported.
Toxicity Oral, rat: LD50 = >15 gm/kg.
Affected Organisms
Yeast and other fungi
Biotransformation Flucytosine is deaminated, possibly by gut bacteria or by the fungal targets, to 5-fluorouracil, the active metabolite.
Absorption Rapidly and virtually completely absorbed following oral administration. Bioavailability 78% to 89%.
Half Life 2.4 to 4.8 hours.
Protein Binding 28-31%
Elimination Flucytosine is excreted via the kidneys by means of glomerular filtration without significant tubular reabsorption.
A small portion of the dose is excreted in the feces.
External Links
Wikipedia
RxList
Drugs.com

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle